PlainRecalls
FDA Drug Critical Class I Ongoing

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Reported: December 3, 2025 Initiated: November 6, 2025 #D-0182-2026

Product Description

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Reason for Recall

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
2,199,850 vials
Distribution
Nationwide within the United States as well as AK, HI, and PR.
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).. Recalled by Fresenius Kabi USA, LLC. Units affected: 2,199,850 vials.
Why was this product recalled?
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 3, 2025. Severity: Critical. Recall number: D-0182-2026.